RevMedica Inc

Advancing Surgical Stapling Beyond What Can Be Seen

For decades, surgical stapling innovation has focused on the device. RevMedica is shaping a future where real-time insight empowers every stapling decision.

CONFIDENCE BEGINS
WITH CLARITY

RevMedica is engineering the first surgical stapling platform designed to give surgeons objective, real-time tissue data — before, during, and after each deployment.

Closing the Data Gap

RevMedica is empowering surgeons with objective, actionable insight before, during, and after stapler deployment – recommending the correct size reload, adjusting deployment speed, and providing real-time compression guidance.

Improper reload selection and lack of adequate tissue intelligence have been directly linked to staple line complications and serious injuries – outcomes that are costly for patients and hospitals.¹

Surgeon-Centric.
Insight-Driven.
Outcome-Focused.

Surgeons have long sought greater insight at the moment of stapling.

RevMedica is turning insight into action to empower surgeons with greater clarity, confidence, and data to support more informed decisions.

Engineering What's Next

The next generation of surgical stapling is challenging convention with a deeper understanding, real-time insight, and technologies that augment surgeon experience.

RevMedica unites engineers, clinical experts, industry leaders, and surgeon advisors to challenge convention and shape this surgical stapling future.

Turning Possibility
Into Technology

Our Mission:
To optimize clinical decision-making and improve patient safety with cost-effective, environmentally-friendly surgical systems.​

Join the Conversation

RevMedica collaborates with surgeons, healthcare providers, and technology partners to advance surgical stapling beyond what can be seen.
Interested in learning more?

1. U.S. Food and Drug Administration (FDA.gov). Safe Use of Surgical Staplers and Staples – Letter to Health Care Providers. March 8, 2019.

Thomas Wenchell

Chief Executive Officer and Co-Founder
Thomas Wenchell, Co-Founder and CEO of RevMedica
Tom co-founded RevMedica in 2017, with the vision to revolutionize surgical procedures.
 
With over 30 years of experience in the medical device industry and a wealth of expertise in engineering and product development, Tom has established himself as a global leader in the field. He possesses over 100 issued patents, a testament to his innovative contributions to the industry. 
Tom's accomplishments speak to his ability to navigate complex challenges and drive innovation in the medical device industry. At RevMedica, Tom leads the development of a novel, handheld robotic solution intended to optimize clinical decision-making and improve patient safety with a cost-effective and environmentally friendly surgical system.
 
Under his leadership, RevMedica has amassed a robust patent portfolio, assembled a team of key advisers, and successfully demonstrated the feasibility of RevMedica’s core design. Tom’s visionary leadership extends beyond product development.
 
He has played a pivotal role in shaping RevMedica's strategic direction, building a talented team, and securing funding to support the company's growth. His hands-on approach to every aspect of the business underscores his dedication to ensuring the success of RevMedica.